In patients who were diagnosed early and treated appropriately with cessation of ASMs, there may be significant improvement in cognition, particularly in executive and language functions and adherence with other treatments. 35 , 36 , 37 Because 60%–90% of patients with epilepsy report adverse effects of ASMs, which have a significant impact on quality of life, patients are often eager to come off
← all excerpts
Proposed criteria of levels of evidence for co-occurring epilepsy in people with functional/dissociative seizures.
1
—
—